Letermovir improves the outcome of allogenic stem cell transplantation with anti-thymocyte globulin against acute leukemia and myelodysplastic syndromes

Abstract Graft versus host disease (GVHD) is a serious side effect of allogenic stem cell transplantation (allo-SCT). Anti-thymocyte globulin (ATG) reduces GVHD but raises the risk of infections following allo-SCT. Preventive therapy is recommended for cytomegalovirus (CMV), which is a major pathoge...

Cijeli opis

Bibliografski detalji

Glavni autori:	Shuto Negishi, Kotaro Miyao, Fumiya Ohara, Kenta Motegi, Hiroya Wakabayashi, Hitomi Sawa, Yuichiro Inagaki, Masashi Sawa
Format:	Artigo
Jezik:	Inglês
Izdano:	Springer 2026-04-01
Serija:	Annals of Hematology
Teme:	Graft versus host disease Allogenic stem cell transplantation Letermovir Anti-thymocyte globulin
Online pristup:	https://doi.org/10.1007/s00277-026-06964-8
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!